Bio-Rad Labs (BIO) Tops Q2 EPS by 88c
Get Alerts BIO Hot Sheet
Revenue Growth %: -7.0%
Financial Fact:
Income from operations: 22.53M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.54, $0.88 better than the analyst estimate of $2.66. Revenue for the quarter came in at $715.9 million versus the consensus estimate of $631.78 million.
2021 Financial Outlook:
For the full year 2021, the company has updated its guidance and now anticipates non-GAAP currency-neutral revenue growth between 10.0 to 10.5 percent and an estimated non-GAAP operating margin of approximately 19.0 percent. Management will discuss this outlook in greater detail on the second-quarter 2021 financial results conference call.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- WM (WM) Tops Q1 EPS by 25c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!